hares of Blue Jet Healthcare Limited slipped as much as 6.7% to ₹939.40 in Monday’s session even after the company reported robust Q1 FY26 results. The stock opened near its previous close of ₹1,006.80 but witnessed sharp selling towards midday, hitting a low of ₹922.40.
For the quarter ended June 30, 2025, the company posted stellar numbers:
-
Revenue from operations more than doubled to ₹354.76 crore from ₹162.90 crore in Q1 FY25, up 118% YoY.
-
Total income, including other income, rose to ₹363.01 crore from ₹171.61 crore.
-
EBITDA jumped 174% YoY to ₹121 crore, with margins improving to 34.11% versus 27.17% last year.
-
Net profit came in at ₹91.17 crore, surging 141% YoY from ₹37.77 crore.
These strong financials reflected improved operating efficiencies, higher sales, and better cost management.
So why is the stock falling despite the impressive results?
According to market analysts, the sharp decline is likely due to profit booking and a relatively weak sequential (QoQ) performance compared to Q4 FY25.
After a steady rally — with the stock recently touching a 52-week high of ₹1,027.80 — many investors appear to have locked in gains following the earnings announcement. Profit booking is common after a significant run-up in anticipation of a short-term correction, even when fundamentals remain strong.
In addition, while the company showed exceptional growth on a YoY basis, its sequential numbers from Q4 FY25 were lower. In the previous quarter, the company had posted higher EBITDA and net profit, and some investors may have been disappointed by the QoQ moderation despite the annual growth.
Key Financial Metrics (₹ crore)
| Particulars | Q1 FY26 (30-Jun-25) | Q4 FY25 (31-Mar-25) | Q1 FY25 (30-Jun-24) |
|---|---|---|---|
| Revenue from Operations | ₹354.76 | ₹340.44 | ₹162.90 |
| Other Income | ₹8.25 | ₹12.22 | ₹8.71 |
| Total Income | ₹363.01 | ₹352.67 | ₹171.61 |
| Total Expenses | ₹240.15 | ₹205.46 | ₹122.15 |
| Profit before Tax (PBT) | ₹122.86 | ₹147.21 | ₹49.47 |
| Tax Expenses | ₹31.69 | ₹37.12 | ₹11.69 |
| Net Profit | ₹91.17 | ₹110.09 | ₹37.77 |
At the time of writing, the stock was trading at ₹939.40, down 6.69% for the day, with a market cap of ₹16,293 crore and a P/E ratio of 53.55.
Key Financial Metrics (₹ crore)
| Metric | Q1 FY26 (Jun 2025) | Q1 FY25 (Jun 2024) | YoY Growth |
|---|---|---|---|
| Revenue from Operations | ₹354.76 | ₹162.90 | +118% |
| Total Income | ₹363.01 | ₹171.61 | +111% |
| EBITDA | ₹121 | ₹44.2 | +174% |
| EBITDA Margin (%) | 34.11% | 27.17% | +694 bps |
| Profit Before Tax (PBT) | ₹122.86 | ₹49.47 | +148% |
| Net Profit | ₹91.17 | ₹37.77 | +141% |
The combination of investors booking profits at higher levels and cautious sentiment over weaker sequential numbers contributed to the decline, even as the company’s annual growth remains strong.
